Vivos (RDGL) FCF Margin (QoQ) (2011 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Vivos | - | - | -3,105.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.22 Mn |
| Sep 30, 2025 | -2.04 Mn |
| Jun 30, 2025 | -232,826.00 |
| Mar 31, 2025 | 772,587.00 |
| Dec 31, 2024 | 69,747.00 |
| Sep 30, 2024 | -749,246.00 |
| Jun 30, 2024 | 517,750.00 |
| Sep 30, 2023 | 166,564.00 |
| Jun 30, 2023 | 5,778.00 |
| Mar 31, 2023 | -55,974.00 |
| Dec 31, 2022 | 1,944.00 |
| Sep 30, 2022 | -272,374.00 |
| Jun 30, 2022 | 132,643.00 |
| Dec 31, 2019 | -1.46 Mn |
| Sep 30, 2016 | 9.98 Mn |
| Jun 30, 2016 | -838,466.00 |
| Jun 30, 2014 | -26,804.00 |
| Mar 31, 2013 | -182,115.00 |
| Dec 31, 2012 | 59,976.00 |
| Sep 30, 2012 | 6,199.00 |
| Jun 30, 2012 | -64,588.00 |
| Mar 31, 2012 | 17,563.00 |
| Dec 31, 2011 | -20,075.00 |
| Sep 30, 2011 | 10,466.00 |
| Jun 30, 2011 | -26,162.00 |
| Mar 31, 2011 | 22,651.00 |